取締役Directors

• 

  代表取締役社長
  小林 茂 工学修士 President, Chief Executive Officer
  Shigeru Kobayashi M.E.

  協和発酵工業（株）（現・協和キリン（株））、Kyowa Hakko UK Ltd.（現・Kyowa Kirin Ltd.）社長、Kyowa Pharmaceutical, Inc.（現・Kyowa Kirin Pharmaceutical Development, Inc.）社長、当社取締役を経て、現任 Shigeru Kobayashi has previously worked at Kyowa Hakko Kogyo Co., Ltd. (currently Kyowa Kirin Co., Ltd.). He has also served as the President at Kyowa Hakko UK, Ltd.（currently Kyowa Kirin Ltd.） and Kyowa Pharmaceutical, Inc. (currently Kyowa Kirin Pharmaceutical Development, Inc.)

• 

  取締役 経営企画室長
  美女平 在彦 Executive Director, Chief Financial Officer, Head of Corporate Planning Officer
  Arihiko Bijohira

  （株）産業育成研究所 、ファイザー（株） 、大鵬薬品（株）、当社コーポレートプランニング部ディレクター、経営企画部長、執行役員コーポレート本部長を経て、現任 Arihiko Bijohira has previously worked at Institute of business Consulting and Investment Co.,Ltd., Pfizer Japan Inc. and Taiho Pharmaceutical Co. Ltd.

• 

  取締役 開発本部長
  田岡 照世 薬学修士 経営学修士 Executive Director, Head of Development Division
  Shose Taoka M.S.,M.B.A.

  協和発酵工業（株）（現・協和キリン株）臨床開発センター臨床開発グループ長、同社中枢神経R＆Dユニットマネジメントオフィス長、当社臨床開発部長、開発本部長を経て、現任 Shose Taoka is the Head of Development Division of Chiome Bioscience inc. He has previously served as General Manager of Clinical Development Center and Director of Central Nervous System R & D Unit at Kyowa Kirin Co., Ltd.

• 

  取締役 研究本部長
  小池 正道 博士（医学） Executive Director, Head of Research Division
  Masamichi Koike Ph.D.

  BioWa, Inc. 社長、Kyowa Hakko Kirin Pharma, Inc.社長、協和キリン（株）研究開発本部 がんR＆Dユニット長、研究機能ユニット長、研究ユニット長を経て、現任 Dr. Masamichi Koike served as President of BioWa, Inc., and President of Kyowa Hakko Kirin Pharma, Inc., and then served as Head of Oncology R&D Unit, Head of Research Function Unit, and Head of Research Unit at Kyowa Kirin Co., Ltd.

• 

  社外取締役
  久保田 晴久 Executive Director
  Haruhisa Kubota

  厚生省（現 厚生労働省）、医薬品機構（現 独立行政法人医薬品医療機器総合機構）、（財）医療機器センター、第一三共（株）常務執行役員、北里第一三共ワクチン（株）（現 第一三共バイオテック）取締役副社長を経て、国立国際医療研究センター臨床研究センター Haruhisa Kubota has previously worked at Ministry of Health and Welfare, Pharmaceuticals and Medical Devices Agency (PMDA) and Japan Association for the Advancement of Medical Equipment (JAAME). He also served as Managing Executive Officer at Daiichi Sankyo Co., Ltd., and as Executive Vice President at Daiichi Sankyo Biotech Co., Ltd. He currently works at Clinical Research Center of National Center for Global health and Medicine.

監査役Auditors

• 

  常勤監査役（社外）
  降矢 朗行 Audit & Supervisory Board Member
  Akiyuki Furuya

  第一製薬（株）（現第一三共（株））取締役、（株）第一ラジオアイソトープ（現　富士フィルムRIファーマ（株））代表取締役社長、同社 相談役、（株）ペルセウスプロテオミクス代表取締役社長、同社 相談役、当社 社外取締役経て、現任 Director of Daiichi Pharmaceutical Co., Ltd. (currently Daiichi Sankyo Co., Ltd.), President and Representative Director of Daiichi Radioisotope Co., Ltd. (currently Fujifilm RI Pharma Co., Ltd.), and Executive Advisor, President and Representative Director of Perseus Proteomics Co., Ltd. , Advisor of the company, Executive Director of the company, current position.

• 

  社外監査役
  山川 善之 Audit & Supervisory Board Member
  Yoshiyuki Yamakawa

  日本生命保険相互会社、イノテック株式会社、株式会社そーせい代表取締役副社長を経て、 響きパートナーズ株式会社代表取締役社長 Yoshiyuki Yamakawa has previously worked at Nippon life Insurance Company and Innotech Corporation. He has also served as the Executive Vice President at Sosei Co. Ltd. He currently serves as the CEO at Hibiki Partners, Inc.

• 

  社外監査役
  坂本二朗 Audit & Supervisory Board Member
  Niro Sakamoto

  第一ファインケミカル㈱ 執行役員経営企画部長、協和発酵キリン㈱ （現・協和キリン㈱） 経理部長、同社執行役員経営企画部長、同社執行役員総務部長を経て、現任 Niro Sakamoto has previously served as Managing Executive Officer of Corporate Planning Department of Daiichi Fine Chemical Co., Ltd(currently kyowa Pharma Chemical Co.,Ltd) and also served as Managing Executive Officer of Corporate Planning Department and General Affairs Department of Kyowa Kirin Co.,Ltd.